Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting

NCT05932485 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05932485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05932485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2023
Completion date
June 1, 2024
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stellate ganglion block